Kapitelklicken springt direkt hin
Shownotes
<p>What does <strong>Lipoprotein(a)</strong> tell us that a standard lipid panel doesn’t? Should we be testing <strong>everyone</strong> for it? Dive into the <strong>genetics, clinical implications, and evolving management strategies</strong> for Lp(a). Learn how to interpret results, counsel patients, and navigate topics with limited data like <strong>aspirin and PCSK9 inhibitors</strong> in treatment.</p><p>🔹 <strong>Sponsor</strong>: <a href="coreimpodcast.com/Freed"; rel="nofollow">Freed</a> is an AI scribe that listens and writes your note in < 30 seconds. Freed <strong>learns your style</strong> over time and is HIPAA compliant! </p><p>Use the code <strong>CORE50</strong> to get 50% off your first month with <a href="coreimpodcast.com/Freed"; rel="nofollow">Freed</a></p><p>🔹 <a href="coreimpodcast.com/2025/04/02/lpa-and-ascvd-ris…; rel="nofollow"><strong>Transcript and Show Notes</strong></a></p><p><strong>Timestamps:</strong></p><p>() | <strong>Pearl 1</strong>: What makes Lp(a) unique? How does it raise ASCVD risk?</p><p>() | <strong>Pearl 2</strong>: Who should be tested for Lp(a)? When and why?</p><p>() | <strong>Pearl 3</strong>: Understanding and interpreting Lp(a) levels</p><p>() | <strong>Pearl 4</strong>: How does an elevated Lp(a) affect management?</p><p>()| <strong>Pearl 5</strong>: The role of aspirin and PCSK9 inhibitors in Lp(a)</p><p><br></p><p><strong>Tags:</strong> CoreIM, Internal Medicine, Primary Care, Preventive Cardiology, Atherosclerosis, Lipid Management, Medical Education, IMCore, Physician Assistant, Nurse Practitioner, Medical Student</p><br /><br />Find the best disability insurance for you: patternlife.com/disability-insurance?campid=49… Sponsors:<br/>* Check out Eko: ekohealth.com<br/>* Check out FIGS and use my code FIGSRX for a great deal: wearfigs.com<br/><br/><br/>A… Inquiries: <a href='redcircle.com/brands'>https://redcircle… & Opt-Out: <a href='redcircle.com/privacy'>https://redcircl…;
